Published in Curr Oncol Rep on September 01, 2005
Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation. PLoS Pathog (2013) 0.98
Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen. J Biol Chem (2011) 0.97
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol Cancer Ther (2007) 0.86
Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines. J Virol (2006) 0.81
Virus-associated lymphomagenesis. Int J Biomed Sci (2006) 0.79
Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel) (2015) 0.77
Expression and subcellular localization of the KSHV K15P protein during latency and lytic reactivation in primary effusion lymphoma cells. J Virol (2017) 0.75
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A (2005) 5.88
Discovery of a viral NLR homolog that inhibits the inflammasome. Science (2011) 2.36
Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol (2004) 2.20
Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood (2010) 1.60
Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res (2008) 1.57
Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol (2008) 1.57
Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A (2009) 1.55
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett (2009) 1.54
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol (2004) 1.51
The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res (2004) 1.50
Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res (2006) 1.49
The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity (2012) 1.44
Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol (2013) 1.38
Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A (2012) 1.32
Whole-genome transcription profiling of rhesus monkey rhadinovirus. J Virol (2005) 1.24
Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J Virol (2005) 1.22
Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci U S A (2013) 1.14
Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus. J Virol (2006) 1.12
A genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization. J Virol (2006) 1.12
Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes. J Virol (2002) 1.09
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood (2009) 1.09
Rhesus monkey rhadinovirus (RRV): construction of a RRV-GFP recombinant virus and development of assays to assess viral replication. Virology (2003) 1.07
Three-dimensional structures of the A, B, and C capsids of rhesus monkey rhadinovirus: insights into gammaherpesvirus capsid assembly, maturation, and DNA packaging. J Virol (2003) 1.07
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. Front Immunol (2013) 1.07
Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol (2002) 1.05
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis. Cancer Res (2013) 1.04
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog (2013) 1.04
Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus. J Virol (2010) 1.03
The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation. J Virol (2005) 1.01
Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood (2011) 1.01
Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood (2011) 1.00
Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update. Curr Opin Virol (2013) 0.99
Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J Virol (2009) 0.97
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. Front Microbiol (2012) 0.97
Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. Virology (2006) 0.96
Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS Pathog (2012) 0.95
Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines. J Virol (2012) 0.95
The viral interferon regulatory factors of KSHV: immunosuppressors or oncogenes? Front Immunol (2011) 0.94
The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3. J Virol (2012) 0.92
Viral profiling identifies multiple subtypes of Kaposi's sarcoma. MBio (2014) 0.92
The Kaposi's sarcoma-associated herpesvirus ORF6 DNA binding protein forms long DNA-free helical protein filaments. J Struct Biol (2010) 0.91
Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. J Virol (2009) 0.90
Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A. Virology (2012) 0.90
An important role for mitochondrial antiviral signaling protein in the Kaposi's sarcoma-associated herpesvirus life cycle. J Virol (2014) 0.90
Tousled-like kinases modulate reactivation of gammaherpesviruses from latency. Cell Host Microbe (2013) 0.89
Comparative transmission of multiple herpesviruses and simian virus 40 in a baboon breeding colony. Comp Med (2004) 0.88
NLRs, inflammasomes, and viral infection. J Leukoc Biol (2012) 0.88
The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus. J Virol (2013) 0.87
Critical role for endocytosis in the regulation of signaling by the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol (2008) 0.86
Toll-like receptor sensing of human herpesvirus infection. Front Cell Infect Microbiol (2012) 0.86
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol Cancer Ther (2007) 0.86
Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer (2013) 0.86
Kaposi's sarcoma-associated herpesvirus and innate immunity. Future Virol (2010) 0.85
Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene. J Virol (2006) 0.83
Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest (2016) 0.82
KSHV and the toll of innate immune activation. Cell Cycle (2009) 0.81
Inhibition of the inflammasome response by a viral protein that interacts with NLRs. Commun Integr Biol (2011) 0.80
Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes. J Virol (2007) 0.79
KSHV-associated disease in the AIDS patient. Cancer Treat Res (2007) 0.79
Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma. Clin Adv Hematol Oncol (2010) 0.79
Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma. Leuk Lymphoma (2014) 0.78
Rapalogs in viral cancers. Expert Opin Investig Drugs (2012) 0.78
KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation. Virology (2013) 0.77
Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals. AIDS (2017) 0.75